Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tremelimumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02701400
What this trial is testing

Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
Emory University 18
Testing effectiveness (Phase 2)UnknownNCT03959293
What this trial is testing

Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastric Cancer
Federation Francophone de Cancerologie Digestive 107
Early research (Phase 1)Study completedNCT02040064
What this trial is testing

Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 27
Testing effectiveness (Phase 2)Study completedNCT03317457
What this trial is testing

Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Metastatic Adult Soft Tissue SarcomaRecurrent Adult Soft Tissue Sarcoma
AIO-Studien-gGmbH 103
Large-scale testing (Phase 3)Active Not RecruitingNCT03682068
What this trial is testing

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

Who this might be right for
Unresectable Locally Advanced Urothelial CancerMetastatic Urothelial Cancer
AstraZeneca 1,246
Early research (Phase 1)Study completedNCT02000947
What this trial is testing

A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLCNon-small Cell Lung CancerLung Cancer
MedImmune LLC 459
Testing effectiveness (Phase 2)Ended earlyNCT03522584
What this trial is testing

Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
University of Washington 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03837899
What this trial is testing

Durvalumab and Tremelimumab for Pediatric Malignancies

Who this might be right for
Pediatric CancerSolid Tumor PediatricHematological Malignancies
AstraZeneca 50
Early research (Phase 1)Ended earlyNCT03963414
What this trial is testing

Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLC

Who this might be right for
Small Cell Lung Carcinoma
University of Nebraska 1
Testing effectiveness (Phase 2)Study completedNCT03249142
What this trial is testing

Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT03057106
What this trial is testing

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Who this might be right for
Lung Cancer Metastatic
Canadian Cancer Trials Group 301
Testing effectiveness (Phase 2)Study completedNCT00313794
What this trial is testing

Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment

Who this might be right for
Colorectal Neoplasms
AstraZeneca 49
Large-scale testing (Phase 3)Looking for participantsNCT06904170
What this trial is testing

Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
UNICANCER 196
Testing effectiveness (Phase 2)Study completedNCT03007407
What this trial is testing

Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy

Who this might be right for
Colorectal Cancer Metastatic
NSABP Foundation Inc 33
Testing effectiveness (Phase 2)UnknownNCT03737968
What this trial is testing

Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.

Who this might be right for
Stage II-IVB Operable HNSCC Oral CavityHypopharynxOropharynx+1 more
Yonsei University 48
Testing effectiveness (Phase 2)UnknownNCT01649024
What this trial is testing

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese 29
Large-scale testing (Phase 3)Active Not RecruitingNCT03298451
What this trial is testing

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 1,324
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511504
What this trial is testing

Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular Carcinoma

Who this might be right for
Locally Advanced Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8+1 more
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Testing effectiveness (Phase 2)Study completedNCT02527434
What this trial is testing

Study of Tremelimumab in Patients With Advanced Solid Tumors

Who this might be right for
Urothelial Bladder CancerTriple-negative Breast CancerPancreatic Ductal Adenocarcinoma
AstraZeneca 64
Next Page